Celldex Therapeutics

Celldex Therapeutics harnesses the power of the immune system to address a range of devastating diseases in drug development. The company’s pipeline consists of therapeutic antibodies, antibody-drug conjugates, immune system modulators, and vaccines, which Celldex believes have higher success rates because they target specific patient populations with significant unmet medical needs, whose diseases express specific markers, including many underserved or entirely unserved orphan indications. The company is developing monoclonal and bispecific antibodies to tackle devastating diseases with inadequate existing treatments. Our product pipeline includes antibody-based therapies that can activate the body's immune system and/or directly impact critical pathways to improve the lives of patients with inflammatory diseases and various cancers.